Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Asia-Pacific Journal of Oncology Nursing
|
September 5, 2024
Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy
Ninh M La-Beck, Jesuwapelumi Owoso
Frontiers in Immunology
|
April 22, 2017
Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy
Ninh M La-Beck, Alberto A Gabizon
Frontiers in Pharmacology
|
March 28, 2019
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
Ninh M La-Beck, Xinli Liu, Laurence M Wood
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2016
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
Alberto A Gabizon, Yogita Patil, Ninh M La-Beck
Frontiers in Immunology
|
January 25, 2021
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
Ninh M La-Beck, Md Rakibul Islam, Maciej M Markiewski
Asia-Pacific Journal of Oncology Nursing
|
April 2, 2019
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines
Saralinh Trinh, Alex Le, Sajida Gowani, et al.
BMJ Oncology
|
January 31, 2025
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
Alberto A Gabizon, Shira Gabizon-Peretz, Shadan Modaresahmadi, et al.
Advanced Drug Delivery Reviews
|
June 12, 2020
Translational considerations in nanomedicine: The oncology perspective
Alberto A Gabizon, Rafael T M de Rosales, Ninh M La-Beck
Therapeutics and Clinical Risk Management
|
March 7, 2017
Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
Alexander D Le, Saeed K Alzghari, Gary W Jean, et al.
Seminars in Cancer Biology
|
December 25, 2019
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment
Ninh M La-Beck, Xinli Liu, Hilary Shmeeda, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Asia-Pacific Journal of Oncology Nursing
|
September 5, 2024
Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy
Ninh M La-Beck, Jesuwapelumi Owoso
Frontiers in Immunology
|
April 22, 2017
Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy
Ninh M La-Beck, Alberto A Gabizon
Frontiers in Pharmacology
|
March 28, 2019
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
Ninh M La-Beck, Xinli Liu, Laurence M Wood
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2016
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
Alberto A Gabizon, Yogita Patil, Ninh M La-Beck
Frontiers in Immunology
|
January 25, 2021
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
Ninh M La-Beck, Md Rakibul Islam, Maciej M Markiewski
Asia-Pacific Journal of Oncology Nursing
|
April 2, 2019
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines
Saralinh Trinh, Alex Le, Sajida Gowani, et al.
BMJ Oncology
|
January 31, 2025
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
Alberto A Gabizon, Shira Gabizon-Peretz, Shadan Modaresahmadi, et al.
Advanced Drug Delivery Reviews
|
June 12, 2020
Translational considerations in nanomedicine: The oncology perspective
Alberto A Gabizon, Rafael T M de Rosales, Ninh M La-Beck
Therapeutics and Clinical Risk Management
|
March 7, 2017
Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
Alexander D Le, Saeed K Alzghari, Gary W Jean, et al.
Seminars in Cancer Biology
|
December 25, 2019
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment
Ninh M La-Beck, Xinli Liu, Hilary Shmeeda, et al.
Page
of 4